This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
Product | Active Ingredient(s) |
Bupivacaine Hydrochloride 0.25% w/v Solution for Injection PA0073/091/001 Mercury Pharmaceuticals (Ireland) Ltd | Bupivacaine |
Keflex 125mg/5ml Powder for Oral Suspension PA1226/002/002 Flynn Pharma Limited | Cephalexin |
Keflex 250mg/5ml Powder for Oral Suspension PA1226/002/003 Flynn Pharma Limited | Cephalexin |
Olmesartan medoxomil 10mg Film Coated Tablets PA0577/214/001 McDermott Laboratories Ltd., T/A Gerard Laboratories | Olmesartan |
Olmesartan medoxomil 20mg Film Coated Tablets PA0577/214/002 McDermott Laboratories Ltd., T/A Gerard Laboratories | Olmesartan |
Otrivine Congestion Relief Menthol 0.1% w/v Nasal Spray PA0678/120/005 GlaxoSmithKline Consumer Healthcare (Ireland) Limited | Xylometazoline |
Pantup 40mg Gastro Resistant Tablets PA0074/069/001 Rowa Pharmaceuticals Limited | Pantoprazole |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
Product | Active Ingredient(s) |
Abstral 100mcg Sublingual Tablets PA2288/004/002 Kyowa Kirin Holdings B.V. | Fentanyl |
Actilyse Cathflo 2mg Powder for Solution for Injection and Infusion PA0775/011/004 Boehringer Ingelheim International GmbH | Alteplase |
Dalacin T Topical Lotion 10 mg/ml Cutaneous Emulsion PA0822/121/001 Pfizer Healthcare Ireland | Clindamycin |
Desogestrel Rowex 75 microgram Film coated Tablets (84 pack only) PA0711/243/001 Rowex Ltd | Desogestrel |
Gentamicin 10mg/ml Solution for Injection or Infusion PA0281/242/001 Pinewood Laboratories Ltd | Gentamicin |
Letrozole Teva 2.5mg Film Coated Tablets PA0749/085/001 Teva Pharma B.V. | Letrozole |
Methotrexate 5 mg/2 ml Injection PA0822/206/001 Pfizer Healthcare Ireland | Methotrexate |
Mirap 45 mg Film-Coated Tablets PA0711/062/003 Rowex Ltd | Mirtazapine |
Mirap DisTab 45 mg Orodispersible Tablets PA0711/094/003 Rowex Ltd | Mirtazapine |
Montelukast Mylan 5 mg Chewable Tablets PA0577/131/002 McDermott Laboratories Ltd., T/A Gerard Laboratories | Montelukast |
Omeprazole Rowa 20 mg Gastro-resistant Capsules PA0074/075/002 Rowa Pharmaceuticals Limited | Omeprazole |
Omeprazole Teva 20mg Gastro Resistant Capsules PA0749/160/002 Teva Pharma B.V. | Omeprazole |
Pregabalin Krka 50mg Hard Capsules PA1347/050/002 KRKA, d.d., Novo mesto | Pregabalin |
Rispone 1 mg/ml oral solution PA0711/106/001 Rowex Ltd | Risperidone |
Rosuvastatin Teva Pharma 10 mg Film-coated Tablets PA1986/024/002 Teva B.V. | Rosuvastatin |
Rosuvastatin Teva Pharma 40 mg Film-coated Tablets PA1986/024/004 Teva B.V. | Rosuvastatin |
Sperizak 37.5mg powder and solvent for prolonged-release suspension for injection PA2315/248/002 Accord Healthcare Ireland Ltd | Risperidone |
Triapin 5mg/5mg Prolonged Release Tablets PA0540/082/001 Sanofi-Aventis Ireland Limited T/A SANOFI | Felodipine & ramipril |
Voriconazole Teva 200 mg Film-coated Tablets PA0749/181/001 Teva Pharma B.V. | Voriconazole |
Zoledronic acid Mylan 4 mg/5ml Concentrate for solution for infusion PA0577/131/002 McDermott Laboratories Ltd., T/A Gerard Laboratories | Zoledronic acid |
Zyvox 600mg Film Coated Tablets PA0822/143/004 Pfizer Healthcare Ireland | Linezolid |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.